KVAC Logo

Keen Vision Acquisition Corporation - Ordinary Shares (KVAC) Stock Forecast & Price Prediction

Live KVAC Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | Financial Services | Shell Companies

$11.10

-0.01 (-0.09%)

12 Month Price Forecast For KVAC

$11.10
Current Price
$214.96M
Market Cap
0 Ratings
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to KVAC Price Forecasts

N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A

KVAC Price Momentum

0.0%
1 Week Change
+0.9%
1 Month Change
+6.9%
1 Year Change
+1.1%
Year-to-Date Change
-0.1%
From 52W High of $11.11
+7.0%
From 52W Low of $10.37

๐Ÿค” Considering Keen Vision (KVAC)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 10, 2025 7:21 PM UTC

KVAC Analyst Ratings & Price Targets

Currently, there are no Wall Street analyst price targets or forecasts available for KVAC (Keen Vision).

KVAC is currently trading at $11.10. Without active analyst coverage, investors should conduct thorough independent research and consider multiple data points beyond price targets when evaluating this stock for their portfolio.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

KVAC Analyst Consensus

0
Buy
0
Hold
0
Sell

KVAC Price Target Range

Low
N/A
Average
N/A
High
N/A
Current: $11.10

Latest KVAC Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for KVAC.

Date Firm Analyst Rating Change Price Target

Stocks Similar to Keen Vision Acquisition Corporation - Ordinary Shares

The following stocks are similar to Keen Vision based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Keen Vision Acquisition Corporation - Ordinary Shares (KVAC) Financial Data

Keen Vision Acquisition Corporation - Ordinary Shares has a market capitalization of $214.96M with a P/E ratio of 14.8x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.

Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +1.0%.

Valuation Metrics

Market Cap $214.96M
Enterprise Value $215.02M
P/E Ratio 14.8x
PEG Ratio 0.0x
Price/Sales 0.0x

Growth & Margins

Revenue Growth (YoY) N/A
Gross Margin N/A
Operating Margin 0.0%
Net Margin 0.0%
EPS Growth N/A

Financial Health

Cash/Price Ratio +0.0%
Current Ratio 0.2x
Debt/Equity 0.0x
ROE +1.0%
ROA +0.9%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Keen Vision Acquisition Corporation - Ordinary Shares logo

Keen Vision Acquisition Corporation - Ordinary Shares (KVAC) Company Overview

About Keen Vision Acquisition Corporation - Ordinary Shares

What They Do

Special purpose acquisition company targeting various sectors.

Business Model

The company operates as a special purpose acquisition company (SPAC), aiming to raise capital through an initial public offering (IPO) to acquire or merge with existing businesses in the biotechnology, consumer goods, and agriculture sectors. It generates revenue primarily from the successful completion of such business combinations.

Additional Information

Incorporated in 2021, Keen Vision Acquisition Corporation is located in Summit, New Jersey. As a SPAC, it does not have significant operations of its own but seeks to identify and partner with promising businesses to enhance shareholder value.

Company Information

Sector

Financial Services

Industry

Shell Companies

Employees

0

CEO

Mr. Ka Chun Wong

Country

United States

IPO Year

2023

Keen Vision Acquisition Corporation - Ordinary Shares (KVAC) Latest News & Analysis

KVAC stock latest news image
Quick Summary

Medera, Inc., a clinical-stage biotech firm, will participate in two investor conferences in February 2025, according to their announcement on February 7, 2025.

Why It Matters

Medera's participation in investor conferences highlights its growth potential and may attract investor interest, influencing stock performance and funding opportunities.

Source: GlobeNewsWire
Market Sentiment: Neutral
KVAC stock latest news image
Quick Summary

A new study utilizes AI and ML with Medera's mini-Heart platform to enhance drug screening efficiency, potentially reducing costs and improving safety in drug development.

Why It Matters

The study's integration of AI/ML with human mini-Hearts could revolutionize drug development, reducing costs and failure rates, which may lead to more profitable investments in biotech firms.

Source: PRNewsWire
Market Sentiment: Neutral
KVAC stock latest news image
Quick Summary

Medera Inc.'s subsidiary, Sardocor Corp., reported positive results from its low-dose SRD-002 therapy for heart failure. Cohort B dosing has begun, following recommendations from the DSMB.

Why It Matters

The development of effective therapies for heart failure, particularly HFpEF, indicates potential market growth for Medera Inc., impacting stock performance and investor interest in the biotech sector.

Source: PRNewsWire
Market Sentiment: Neutral
KVAC stock latest news image
Quick Summary

Monteverde & Associates PC has been recognized as a Top 50 firm in the ISS Securities Class Action Services Report (2018-2022) for recovering funds for shareholders.

Why It Matters

Recognition of Monteverde & Associates as a top firm in securities class actions highlights its effectiveness in protecting shareholder interests, potentially influencing investor confidence and stock valuations.

Source: PRNewsWire
Market Sentiment: Neutral
KVAC stock latest news image
Quick Summary

Medera, a clinical-stage biotech firm, is merging to enhance its AAV-based gene therapy programs, targeting $40M liquidity. The deal values the combined company at ~$622.6M, closing Q4 2024.

Why It Matters

Medera's merger and substantial funding commitment signal strong backing for its innovative gene therapy programs, potentially enhancing its market position and valuation, impacting investor outlook.

Source: PRNewsWire
Market Sentiment: Neutral
KVAC stock latest news image
Quick Summary

Keen Vision Acquisition Corporation announced that starting September 15, 2023, investors can separately trade its ordinary shares and warrants on Nasdaq.

Why It Matters

The ability to trade KVAC's ordinary shares and warrants separately enhances liquidity and investment options, potentially impacting stock price volatility and investor interest.

Source: PRNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About KVAC Stock

What is Keen Vision Acquisition Corporation - Ordinary Shares's (KVAC) stock forecast for 2025?

Analyst forecasts for Keen Vision Acquisition Corporation - Ordinary Shares (KVAC) are not currently available. The stock is trading at $11.10.

Is KVAC stock a good investment in 2025?

Analyst ratings for KVAC are not currently available. The stock is currently trading at $11.10. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for KVAC stock?

Price predictions from Wall Street analysts for KVAC are not currently available. The stock is trading at $11.10.

What is Keen Vision Acquisition Corporation - Ordinary Shares's business model?

The company operates as a special purpose acquisition company (SPAC), aiming to raise capital through an initial public offering (IPO) to acquire or merge with existing businesses in the biotechnology, consumer goods, and agriculture sectors. It generates revenue primarily from the successful completion of such business combinations.

What is the highest forecasted price for KVAC Keen Vision Acquisition Corporation - Ordinary Shares?

Price targets from Wall Street analysts for KVAC are not currently available. The stock is trading at $11.10.

What is the lowest forecasted price for KVAC Keen Vision Acquisition Corporation - Ordinary Shares?

Price targets from Wall Street analysts for KVAC are not currently available. The stock is trading at $11.10.

What is the overall KVAC consensus from analysts for Keen Vision Acquisition Corporation - Ordinary Shares?

Analyst ratings for KVAC are not currently available. The stock is trading at $11.10.

How accurate are KVAC stock price projections?

Stock price projections, including those for Keen Vision Acquisition Corporation - Ordinary Shares, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.